Clinical Trial

Study of SNH-118110 in Advanced Solid Tumors

Name: Study of SNH-118110 in Advanced Solid Tumors — clinical trial record (NCT07649200)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SNH-118110

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a multicenter, open-label, Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of SNH-118110 administered orally. The study consists of a dose-escalation phase and a dose-expansion phase.

Trial Details

NCT Number	NCT07649200
Lead Sponsor	ScinnoHub Pharmaceutical Co., Ltd.
Conditions	Solid Tumors
Enrollment	240 participants
Start Date	2026-06-26
Primary Completion	2027-06-26 (estimated)
Study Completion	2029-06-26 (estimated)
Updated on ClinicalTrials.gov	2026-06-16